You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts

Last Updated: September 29, 2023

NORTHERA Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Northera patents expire, and what generic alternatives are available?

Northera is a drug marketed by Lundbeck Na Ltd and is included in one NDA.

The generic ingredient in NORTHERA is droxidopa. There are six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the droxidopa profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Northera

A generic version of NORTHERA was approved as droxidopa by AJANTA PHARMA LTD on February 18th, 2021.

  Try a Trial

Summary for NORTHERA
Drug patent expirations by year for NORTHERA
Drug Prices for NORTHERA

See drug prices for NORTHERA

Recent Clinical Trials for NORTHERA

Identify potential brand extensions & 505(b)(2) entrants

H. Lundbeck A/SPhase 2
Loma Linda UniversityPhase 2
Stephen G. Kaler, MDPhase 1/Phase 2

See all NORTHERA clinical trials

Pharmacology for NORTHERA
Physiological EffectIncreased Blood Pressure

US Patents and Regulatory Information for NORTHERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-003 Feb 18, 2014 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.